A new cross-sectional study published in Vaccine of US adults demonstrates that people who received the COVID-19 booster vaccine had 25% lower odds of having long COVID than their unvaccinated counterparts. https://t.co/ETYLP2QEBT
A new cross-sectional study published in Vaccine of US adults demonstrates that people who received the COVID-19 booster vaccine had 25% lower odds of having long COVID than their unvaccinated counterparts. https://t.co/dfamydhJnF
A new cross-sectional study published in Vaccine of US adults demonstrates that people who received the COVID-19 booster vaccine had 25% lower odds of having long COVID than their unvaccinated counterparts. https://t.co/BWQ1nPlWsl
Las personas que recibieron una tercera dosis de vacunas contra #COVID19, cómo BNT162b2 o mRNA-1273 dado que el estudio ha evaluado una población estadounidense, tuvieron una probabilidad de desarrollar Sd Post COVID-19 de un 25%, es decir, ⬇️75%. 2/2 htt